Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 875 of 981 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/01/20
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 01/01/22
Due: 01/01/23
Phase: N/A
Priority: Normal
Start: 12/01/22
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 09/02/20
End: 05/30/26
Due: 05/30/27
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 06/01/24
Due: 06/01/25
Phase: N/A
Priority: Normal
Start: 09/11/20
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 03/01/17
End: 07/30/17
Due: 07/30/18
Phase: N/A
Priority: Normal
Start: 08/22/22
End: 04/30/23
Due: 04/30/24
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 12/01/26
Due: 12/01/27
Phase: N/A
Priority: Normal
Start: 02/02/23
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 11/01/18
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 08/31/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 11/20/19
End: 05/25/22
Due: 05/25/23
Phase: N/A
Priority: Normal
Start: 01/01/22
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 01/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/23/20
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 10/30/24
Due: 10/30/25
Phase: N/A
Priority: Normal
Start: 05/12/21
End: 06/29/24
Due: 06/29/25
Phase: N/A
Priority: Normal
Start: 11/30/23
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 11/30/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 12/31/17
Due: 12/31/18
The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 06/01/24
Due: 06/01/25